[Form 4] GENTEX CORP Insider Trading Activity

Rhea-AI Filing Summary

GENTEX CORP Chief Technology Officer Neil Boehm reported multiple stock transactions involving company common stock. He received a grant of 14,953 shares on February 19, 2026 and a grant of 31,993 performance-based shares on February 17, 2026, both at a stated price of $0.00 per share, reflecting equity awards rather than purchases.

Also on February 17, 2026, shares were withheld to cover tax obligations at $24.89 per share in two transactions totaling 17,768 shares, and he executed open-market sales at $24.82 per share in two transactions totaling 11,248 shares. After these transactions, he directly owned 58,951 shares of Gentex common stock.

Insider Trade Summary

Net Seller: 11,248 shares ($279,175)

Net Sell 6 txns

Insider Boehm Neil

Role Chief Technology Officer

Sold 11,248 shs ($279K)

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,953	$0.00	--
Grant/Award	Common Stock	31,993	$0.00	--
Tax Withholding	Common Stock	14,160	$24.89	$352K
Sale	Common Stock	8,916	$24.82	$221K
Tax Withholding	Common Stock	3,608	$24.89	$90K
Sale	Common Stock	2,332	$24.82	$58K

Holdings After Transaction: Common Stock — 73,904 shares (Direct)

Footnotes (1)

1. 31,993 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan These shares vest 100% three years from grant award date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boehm Neil

(Last) (First) (Middle)

600 NORTH CENTENNIAL STREET

(Street)

ZEELAND MI 49464

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GENTEX CORP [ GNTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		A(1)		31,993	A	$0.00	87,967(2)	D
Common Stock	02/17/2026		F		14,160	D	$24.89	73,807	D
Common Stock	02/17/2026		S		8,916	D	$24.82	64,891	D
Common Stock	02/17/2026		F		3,608	D	$24.89	61,283	D
Common Stock	02/17/2026		S		2,332	D	$24.82	58,951	D
Common Stock	02/19/2026		A(3)		14,953	A	$0.00	73,904	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 31,993 shares are performance-based shares where the total number of shares granted were based on long term performance incentives.

2. Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan

3. These shares vest 100% three years from grant award date.

Remarks:

	/s/ Scott Ryan for Neil J Boehm by Power of Attorney	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Gentex (GNTX) CTO Neil Boehm report in this Form 4 filing?

Gentex CTO Neil Boehm reported a mix of equity awards, tax-related share withholdings, and open-market stock sales. The transactions involved common stock grants at $0.00 per share and sales and withholdings around $24.82–$24.89 per share.

How many Gentex (GNTX) shares were granted to Neil Boehm?

Neil Boehm was granted 14,953 Gentex common shares on February 19, 2026 and 31,993 performance-based shares on February 17, 2026. Both grants were reported at a stated price of $0.00 per share as equity awards.

What Gentex (GNTX) shares did Neil Boehm sell or dispose of in this filing?

On February 17, 2026, Neil Boehm had 17,768 Gentex shares disposed of to cover tax liabilities at $24.89 per share and sold 11,248 shares in open-market transactions at $24.82 per share, resulting in a net reduction in his holdings.

What are the performance-based Gentex (GNTX) shares mentioned in the Form 4?

The Form 4 notes that 31,993 of the reported Gentex shares are performance-based, with the total number granted tied to long-term performance incentives. According to the footnote, these shares vest 100% three years from the grant award date.

How many Gentex (GNTX) shares does Neil Boehm own after these transactions?

After the reported grants, tax withholdings, and open-market sales, Neil Boehm directly owns 58,951 Gentex common shares. This figure reflects his direct ownership position immediately following the final transaction disclosed in the Form 4.

Were Neil Boehm’s Gentex (GNTX) transactions open-market buys or equity awards?

The filing shows equity awards and disposals rather than open-market purchases. Shares were acquired through grants at $0.00 per share, while disposals include tax-withholding transactions and open-market sales at prices around $24.82–$24.89 per share.